SCHEMBL2274863

SCHEMBL2274863

CC(=O)N(Cl)c1ccc2c(c1NC(=O)c1ccccc1C)C(=O)c1ccccc1C2=O

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
MAPT P10636 6/20 0.43
HTT P42858 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
POLB P06746 3/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
MAPK1 P28482 2/20 0.43
THRB P10828 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MMP14 P50281 1/20 0.43
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
MAOA P21397 1/20 0.40
ELANE P08246 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2274343 0.89 ALDH1A1 (0.46) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL2268881 0.88 PTPRC (0.47) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL2270069 0.85 PTPRC (0.50) ALDH1A1MAPTMEN1KMT2APOLB
SCHEMBL2270337 0.85 HPGD (0.46) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL2272381 0.85 ACE2 (0.47) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL2269057 0.84 ALDH1A1 (0.41) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL2273092 0.82 ALDH1A1 (0.46) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL2274357 0.82 KMT2A (0.44) ALDH1A1MAPTMEN1KMT2APOLB
SCHEMBL2274384 0.81 MAPT (0.44) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL2270395 0.81 KMT2A (0.41) ALDH1A1MAPTHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530465-B2 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2013-09-10 US claimed
US-20130059862-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof HUANG HSU-SHAN (TW) 2013-03-07 US claimed
US-8530465-B2 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2013-09-10 US disclosed
US-20130059862-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof HUANG HSU-SHAN (TW) 2013-03-07 US disclosed
US-8304415-B2 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2012-11-06 US disclosed
US-20110207739-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2011-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110207739-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof ANXA1, ANXA5, ANXA2 ALDH1A1 1020/4885MAPT 4724/4885HTT 3976/4885
US-20130059862-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof ANXA5, ANXA1, HCCS ALDH1A1 337/4885MAPT 4820/4885HTT 4118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.